← All organizations
Government of Kyrgyzstan
Government
Also known as: Ministry of Health, Kyrgyzstan | National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan | National Center of Cardiology and Internal Medicine, Kyrgyz Republic | National Center of Cardiology and Internal Medicine, Kyrgyzstan | National Center of Phthisiatry, Bishkek, Kyrgyzstan
Highest phase reached
Phase 4
First clinical trial
Aug 17, 2009Last known activity
Jul 15, 2024
Timeline
1990s
- Mar 2, 1992
Government of Kyrgyzstan— Founded
Drugs by trial phase (13 distinct, 28 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Studied for
- Altitude Sickness
- Bacterial Infections
- Hypertension
- Hypertension, Pulmonary
- Hypoxia
- Lung Diseases
- Lung Diseases, Obstructive
- Pulmonary Disease, Chronic Obstructive
- Respiration Disorders
- Respiratory Aspiration
- Respiratory Tract Diseases
- Sleep Apnea Syndromes
- Tuberculosis
- Tuberculosis, Multidrug-Resistant
- Tuberculosis, Pulmonary
Recent trials (48)
- NCT06499727OfficialPhase 4Jul 15, 2024
- NCT06498531OfficialPhase 4Jul 15, 2024
- NCT06498505OfficialPhase 4Jul 15, 2024
- NCT07118462OfficialPhase 4Jul 15, 2024
- NCT04915365Study directorPhase 3Jun 1, 2021
- NCT04913389CollaboratorPhase 3Jun 1, 2021
- NCT04913389Study directorPhase 3Jun 1, 2021
- NCT04915365CollaboratorPhase 3Jun 1, 2021
- NCT03955770CollaboratorPhase 4May 31, 2019
- NCT03561675CollaboratorPhase 4Jun 15, 2018
- NCT03561675Study directorPhase 4Jun 15, 2018
- NCT03536429CollaboratorPhase 4May 28, 2018
- NCT03536507CollaboratorPhase 4May 28, 2018
- NCT03540914Study directorPhase 4May 28, 2018
- NCT03537924Study directorPhase 4May 28, 2018
Details
- Founded
- Bishkek, KG Mar 2, 1992
- Last known activity
- Jul 15, 2024